Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2024 Filed Feb 3, 2024 00:07 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 1,137 | $15.74 | $17,896.38 |
DisclosureSEC source: 0001437749-24-003016 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,423 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:07 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-003016 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:12 UTC |
Smith Jason DrewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003018 · rdgdoc.xml · derivative · entry 10 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,500 Underlying: Ordinary Shares · 16,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F6 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027. F6 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:12 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 6,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003018 · rdgdoc.xml · derivative · entry 9 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,334 Underlying: Ordinary Shares · 6,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F5 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. F5 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:12 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003018 · rdgdoc.xml · derivative · entry 8 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Ordinary Shares · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. F4 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:12 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 834 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003018 · rdgdoc.xml · derivative · entry 7 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:12 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 3,328 | $15.74 | $52,382.72 |
DisclosureSEC source: 0001437749-24-003018 · rdgdoc.xml · nonDerivative · entry 6 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,414 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:12 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 6,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-003018 · rdgdoc.xml · nonDerivative · entry 5 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:12 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 1,248 | $15.74 | $19,643.52 |
DisclosureSEC source: 0001437749-24-003018 · rdgdoc.xml · nonDerivative · entry 4 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,076 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:12 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-003018 · rdgdoc.xml · nonDerivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:12 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 417 | $15.74 | $6,563.58 |
DisclosureSEC source: 0001437749-24-003018 · rdgdoc.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,824 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:12 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-003018 · rdgdoc.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:05 UTC |
Kim DongChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003014 · rdgdoc.xml · derivative · entry 3 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027. F3 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:05 UTC |
Kim DongChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003014 · rdgdoc.xml · derivative · entry 2 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,667 Underlying: Ordinary Shares · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. F2 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:05 UTC |
Kim DongChief Financial Officer
|
Exercise / conversionOrdinary Shares | 3,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-003014 · rdgdoc.xml · nonDerivative · entry 1 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:04 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 87,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003012 · rdgdoc.xml · derivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,615 Underlying: Ordinary Shares · 87,615 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027. F2 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027. Read SEC document |
| January 31, 2024 Filed Feb 12, 2024 22:47 UTC Amendment |
Kim DongChief Financial Officer
|
Exercise / conversionOrdinary Shares | 3,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-003794 · rdgdoc.xml · nonDerivative · entry 1 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · balance_after: This amendment corrects and restates the Amount of Securities Beneficially Owned Following Reported Transaction reported in the original Form 4 filed on February 2, 2024. Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:40 UTC |
Schoenberg MarkChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025476 · rdgdoc.xml · derivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F2 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026 F2 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026 Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 15:42 UTC |
Holden StuartDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001437749-23-025482 · rdgdoc.xml · derivative · entry 1 Holden Stuart · CIK 0001763999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2033-09-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:43 UTC |
Belldegrun ArieDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001437749-23-025486 · rdgdoc.xml · derivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2033-09-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:43 UTC |
BUTITTA CYNTHIA MDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001437749-23-025485 · rdgdoc.xml · derivative · entry 1 BUTITTA CYNTHIA M · CIK 0001222082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2033-09-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:42 UTC |
Cohen Fred EDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001437749-23-025484 · rdgdoc.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2033-09-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:42 UTC |
Wildman Daniel GeorgeDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001437749-23-025483 · rdgdoc.xml · derivative · entry 1 Wildman Daniel George · CIK 0001952679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2033-09-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:41 UTC |
Robinson James A. Jr.Director
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001437749-23-025481 · rdgdoc.xml · derivative · entry 1 Robinson James A. Jr. · CIK 0001734295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2033-09-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:41 UTC |
WEN LEANADirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001437749-23-025480 · rdgdoc.xml · derivative · entry 1 WEN LEANA · CIK 0001847598 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2033-09-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:41 UTC |
Smith Jason DrewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025479 · rdgdoc.xml · derivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F2 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026 F2 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026 Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:41 UTC |
Kim DongChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025478 · rdgdoc.xml · derivative · entry 1 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F2 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026 F2 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026 Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 20:28 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 8,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025204 · rdgdoc.xml · derivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vested in three equal installments on November 30, 2021, August 31, 2022 and August 31, 2023. F3 · derivative.expiration_date: The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vested in three equal installments on November 30, 2021, August 31, 2022 and August 31, 2023. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 20:28 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 3,800 | $18.01 | $68,438.00 |
DisclosureSEC source: 0001437749-23-025204 · rdgdoc.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,407 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 20:28 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 8,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-025204 · rdgdoc.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 22:06 UTC |
Cohen Fred EDirector
|
GrantOrdinary Shares | 69,339 | $9.54 | $661,494.06 |
DisclosureSEC source: 0001437749-23-021073 · rdgdoc.xml · nonDerivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer Disclosed balance after: 69,339 F1 · shares: Represents the reporting person's proportionate interest in shares acquired by entities affiliated with Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:30 UTC |
Robinson James A. Jr.Director
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.90 | $0.00 |
DisclosureSEC source: 0001437749-23-020905 · rdgdoc.xml · derivative · entry 1 Robinson James A. Jr. · CIK 0001734295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2033-07-25 F1 · derivative.exercise_date: The shares underlying the stock option vest in equal quarterly installments over 12 months Read SEC document |
| July 25, 2023 Filed Jul 28, 2023 22:05 UTC Amendment |
Robinson James A. Jr.Director
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.84 | $0.00 |
DisclosureSEC source: 0001437749-23-021072 · rdgdoc.xml · derivative · entry 1 Robinson James A. Jr. · CIK 0001734295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2033-07-25 F1 · derivative.exercise_date: The shares underlying the stock option vest in equal quarterly installments over 12 months Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 19:26 UTC |
Schoenberg MarkChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-017046 · rdgdoc.xml · derivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2023. F2 · derivative.expiration_date: The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2023. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · derivative · entry 11 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2033-01-31 F6 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · derivative · entry 10 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F5 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. F5 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · derivative · entry 9 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,667 Underlying: Ordinary Shares · 1,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2022 representing 4,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. F4 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2022 representing 4,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · derivative · entry 8 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Ordinary Shares · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2021 representing 6,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2021 representing 6,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · derivative · entry 7 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F2 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 661 | $10.12 | $6,689.32 |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · nonDerivative · entry 6 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,560 F7 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · nonDerivative · entry 5 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 991 | $10.12 | $10,028.92 |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · nonDerivative · entry 4 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,888 F7 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · nonDerivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 248 | $10.12 | $2,509.76 |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,879 F7 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:02 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-002336 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 20:40 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
GrantPerformance Stock Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002358 · rdgdoc.xml · derivative · entry 7 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Issuer. F8 · date: The performance stock units were approved by the Board of Directors of the Issuer on January 31, 2023. If the performance stock units are not ratified by the Issuer's shareholders at the Issuer's 2023 annual general meeting, the performance stock units will terminate. F7 · derivative.exercise_date: All shares underlying the performance stock units will vest upon achievement of a corporate milestone event. F7 · derivative.expiration_date: All shares underlying the performance stock units will vest upon achievement of a corporate milestone event. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 20:40 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001437749-23-002358 · rdgdoc.xml · derivative · entry 6 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Ordinary Shares · 125,000 shares Expires 2033-01-31 F5 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 20:40 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002358 · rdgdoc.xml · derivative · entry 5 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Ordinary Shares · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. F4 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 20:40 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 13,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002358 · rdgdoc.xml · derivative · entry 4 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,334 Underlying: Ordinary Shares · 13,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 20:40 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002358 · rdgdoc.xml · derivative · entry 3 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021. F2 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.